Thalidomide-NH-C6-NH-Boc e-amino-PEG3-NH2 hydrochloride Smiles: C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N21

Smiles: C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N21

Treatment of primary colorectal cancer xenografts with the small-molecule BMI-1 inhibitor PTC-209 resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth

Djaballah H

Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor

Ezutromid inhibits CYP1A2 enzymic activity in human liver microsomes (HLM) with an IC50 of 5

Thalidomide-NH-C6-NH-Boc e-amino-PEG3-NH2 hydrochloride Smiles: C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N21Thalidomide NH C6 NH Boc is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used for MI 389 (compound 22) synthesis. MI 389 is a potent phthalimide PROTAC degrader based on the multi targeted receptor tyrosine kinase inhibitor sunitinib (HY 10255A). Product information CAS Number: 2093536 13 9 Molecular Weight: 472. 53 Formula: C24H32N4O6 Chemical Name: tert butyl N (6 {[2 (2,6